Identification of antibodies as biological markers in serum from multiple sclerosis patients by immunoproteomic approach

Journal of Neuroimmunology

Volumn 233, Issue 1-2, 2011, Pages 175-180

  Sakurai, Takeo ^a   Kimura, Akio ^a   Yamada, Megumi ^a   Koumura, Akihiro ^a   Hayashi, Yuichi ^a   Tanaka, Yuji ^a   Hozumi, Isao ^a   Inuzuka, Takashi ^a  

^a GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Autoantibody; Immunoproteome; MtHSP70; Multiple sclerosis; PGAM1

Indexed keywords

ENZYME ANTIBODY; MITOCHONDRIAL HEAT SHOCK PROTEIN 70 ANTIBODY; PHOSPHOGLYCERATE MUTASE 1 ANTIBODY; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ACCURACY; ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; BRAIN INFARCTION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HUMAN; IMMUNOASSAY; IMMUNOBLOTTING; IMMUNOREACTIVITY; MALE; MULTIPLE SCLEROSIS; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PREVALENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; BIOLOGICAL MARKERS; FEMALE; HSP70 HEAT-SHOCK PROTEINS; HUMANS; IMMUNOLOGIC TESTS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PHOSPHOGLYCERATE MUTASE; PROTEOMICS;

EID: 79953326312     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.11.003     Document Type: Article

References (26)

1. Chiba S., Yokota S., Yonekura K., Tanaka S., Furuyama H., Kubota H., Fujii N., Matsumoto H. Autoantibodies against HSP70 family proteins were detected in the cerebrospinal fluid from patients with multiple sclerosis. J. Neurol. Sci. 2006, 241:39-43.
2. Cwiklinska H., Mycko M.P., Luvsannorov O., Walkowiak B., Brosnan C.F., Raine C.S., Selmaj K.W. Heat shock protein 70 associations with myelin basic protein and proteolipid protein in multiple sclerosis brains. Int. Immunol. 2003, 15:241-249.
3. Daugaard M., Rohde M., Jäättelä M. The heat shock protein 70 family: highly homologous proteins with overlapping and distinct functions. FEBS Lett. 2007, 581:3702-3710.
4. Deocaris C.C., Kaul S.C., Wadhwa R. On the brotherhood of the mitochondrial chaperones mortalin and heat shock protein 60. Cell Stress Chaperones 2006, 11:116-128.
5. Gini B., Lovato L., Cianti R., Cecotti L., Marconi S., Anghileri E., Armini A., Moretto G., Bini L., Ferracci F., Bonetti B. Novel autoantigens recognized by CSF IgG from Hashimoto's encephalitis revealed by a proteomic approach. J. Neuroimmunol. 2008, 196:153-158.
6. Hauser S.L., Waubant E., Arnold D.L., Vollmer T., Antel J., Fox R.J., Bar-Or A., Panzara M., Sarkar N., Agarwal S., Lauger-Gould A., Smith C.H., HERMES Trial Group B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N. Engl. J. Med. 2008, 358:676-688.
7. Keegan M., König F., McClelland R., Brück W., Morales Y., Bitsch A., Panitch H., Lassmann H., Weinshenker B., Rodriguez M., Parisi J., Lucchinetti C.F. Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange. Lancet 2005, 366:579-582.
8. Kimura A., Sakurai T., Koumura A., Yamada M., Hayashi Y., Tanaka Y., Hozumi I., Tanaka R., Takemura M., Seishima M., Inuzuka T. High prevalence of autoantibodies against phosphoglycerate mutase 1 in patients with autoimmune central nervous system diseases. J. Neuroimmunol. 2010, 219:105-108.
9. Lefranc D., Almeras L., Dubucquoi S., de Seze J., Vermersch P., Prin L. Distortion of the self-reactive IgG antibody repertoire in multiple sclerosis as a new diagnostic tool. J. Immunol. 2004, 172:669-678.
10. Lefranc D., Launay D., Dubucquoi S., de Seze J., Dussart P., Vermersch M., Hachulla E., Hatron P.Y., Vermersch P., Mouthon L., Prin L. Characterization of discriminant human brain antigenic targets in neuropsychiatric systemic lupus erythematosus using an immunoproteomic approach. Arthritis Rheum. 2007, 56:3420-3432.
11. Lionel A., de Seze J., Didier L., Sandrine F.N., Sylvain D., Patrick V., Lionel P. Evolution of self-reactive IgG antibody repertoires in patients with relapsing-remitting multiple sclerosis. Immunol. Lett. 2005, 97:55-62.
12. Lovato L., Cianti R., Gini B., Marconi S., Bianchi L., Armini A., Anghileri E., Locatelli F., Paoletti F., Franciotta D., Bini L., Bonetti B. Transketolase and 2′, 3′-cyclic-nucleotide 3′-phosphodiesterase type I isoforms are specifically recognized by IgG autoantibodies in multiple sclerosis patients. Mol. Cell. Proteomics 2008, 7:2337-2349.
13. Luchinetti C., Brück W., Parisi J., Scheithauer B., Rodriguez M., Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann. Neurol. 2000, 47:707-717.
14. Lund B.T., Chakryan Y., Ashikian N., Mnatsakanyan L., Bevan C.J., Aguilera R., Gallaher T., Jakowec M.W. Association of MBP peptides with Hsp70 in normal appearing human white matter. J. Neurol. Sci. 2006, 249:122-134.
15. Mathey E.K., Derfuss T., Storch M.K., Williams K.R., Hales K., Woolley D.R., Al-Hayani A., Davies S.N., Rasband M.N., Olsson T., Moldenhauer A., Velhin S., Hohlfeld R., Meinl E., Linington C. Neurofascin as a novel target for autoantibody-mediated axonal injury. J. Exp. Med. 2007, 204:2363-2372.
16. Mizzen L.A., Chang C., Garrels J.I., Welch W.J. Identification, characterization, and purification of two mammalian stress proteins present in mitochondria, grp75, a member of the hsp70 family and hsp58, a homolog of the bacterial groEL protein. J. Biol. Chem. 1989, 264:20664-20675.
17. Mycko M.P., Cwiklinska H., Szymanski J., Szymanska B., Kudla G., Kilianek L., Odyniec A., Brosnan C.F., Selmaj K.W. Inducible heat shock protein 70 promotes myelin autoantigen presentation by the HLA class II. J. Immunol. 2004, 172:202-213.
18. Plebani M., Pittoni M., Celadin M., Bernardi D., Mion M.M. Recent advances in diagnostic technologies for autoimmune diseases. Autoimmun. Rev. 2009, 8:238-243.
19. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C., Johnson K.P., Sibley W.A., Silberberg D.H., Tourtellotte W.W. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 1983, 13:227-231.
20. Quintana F.J., Farez M.F., Viglietta V., Iglesias A.H., Merbl Y., Izquierdo G., Lucas M., Basso A.S., Khoury S.J., Lucchinetti C.F., Cohen I.R., Weiner H.L. Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis. Proc. Natl Acad. Sci. USA 2008, 105:18889-18894.
21. Reindl M., Khalil M., Berger T. Antibodies as biological markers for pathophysiological processes in MS. J. Neuroimmunol. 2006, 180:50-62.
22. Somers V., Govarts C., Somers K., Hupperts R., Medaer R., Stinissen P. Autoantibody profiling in multiple sclerosis reveals novel antigenic candidates. J. Immunol. 2008, 180:3957-3963.
23. Tozzoli R. Recent advances in diagnostic technologies and their impact in autoimmune diseases. Autoimmun. Rev. 2007, 6:334-340.
24. Witte M.E., Bø L., Rodenburg R.J., Belien J.A., Musters R., Hazes T., Wintjes L.T., Smeitink J.A., Geurts J.J., De Vries H.E., van der Valk P., van Horssen J. Enhanced number and activity of mitochondria in multiple sclerosis lesions. J. Pathol. 2009, 219:193-204.
25. Yamagata A., Kristensen D.B., Takeda Y., Miyamoto Y., Okada K., Inamatsu M., Yoshizato K. Mapping of phosphorylated proteins on two-dimensional polyacrylamide gels using protein phosphatase. Proteomics 2002, 2:1267-1276.
26. Yokota S., Chiba S., Furuyama H., Fujii N. Cerebrospinal fluids containing anti-HSP70 autoantibodies from multiple sclerosis patients augment HSP70-induced proinflammatory cytokine production in monocytic cells. J. Neuroimmunol. 2010, 218:129-133.